Alliances
Arvinas expanded an ongoing licensing deal with Genentech.
Loxo Oncology struck a deal with Bayer to develop and commercialize two cancer therapies in a deal that could be worth up to $1.55B.
There’s nothing like a billion-plus dollar deal to make investors happy on a Monday.
Ark will be responsible for preclinical and clinical development of the molecule.
Leti announced today that a team of its researchers is participating in a U.S.-funded project to develop a safe, implantable neural interface system to restore vision by stimulating the visual cortex.
Sanofi will write a check for $40 million upfront.
CMV is a common and potentially serious viral infection in allogeneic HSCT recipients.
Fresh off the heels of a $201M liver disease R&D deal with Dicerna, Boehringer Ingelheim has struck another deal targeting liver disease with MiNA Therapeutics.
Takeda inked a collaboration deal to develop and commercialize Portal’s needle-free drug delivery device for use with some of Takeda’s biologic medicines.
PRESS RELEASES